Ocugen (OCGN) Other Working Capital Changes (2014 - 2026)
Ocugen (OCGN) reported Other Working Capital Changes of $927000.0 for Q1 2026, up 575.38% on a YoY basis from $137255.1 in Q1 2025, and down 63.17% quarter-over-quarter from $2.5 million in Q4 2025.
Ocugen (OCGN) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Ocugen has reported Other Working Capital Changes for 13 years, with the latest figure at $927000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 575.38% year-over-year to $927000.0; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (up 519.46% YoY), and the FY2025 full-year result was $2.6 million, up 412.97% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $927000.0, down from $2.5 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.5 million in Q4 2025, with the low at -$840000.0 in Q2 2022.
- Historically, Other Working Capital Changes has averaged $105941.2 across 5 years, with a median of -$122000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes soared 4650.0% — and 2024, when it plunged 331.67%.
- Ocugen's Other Working Capital Changes stood at -$122000.0 in 2022, then slipped by 10.66% to -$135000.0 in 2023, then slumped by 60.0% to -$216000.0 in 2024, then jumped by 1265.28% to $2.5 million in 2025, then tumbled by 63.17% to $927000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $927000.0 (Q1 2026), $2.5 million (Q4 2025), and $686000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 927,000.00 |
| Mar 31, 2026 | 927,000.00 |
| Dec 31, 2025 | 2.52 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 686,000.00 |
| Sep 30, 2025 | 686,000.00 |
| Jun 30, 2025 | -401,000.00 |
| Jun 30, 2025 | -401,000.00 |
| Mar 31, 2025 | -195,000.00 |
| Mar 31, 2025 | -195,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Sep 30, 2024 | -50,000.00 |
| Sep 30, 2024 | -50,000.00 |
| Jun 30, 2024 | -428,000.00 |
| Jun 30, 2024 | -428,000.00 |
| Mar 31, 2024 | -139,000.00 |
| Mar 31, 2024 | -139,000.00 |
| Dec 31, 2023 | -135,000.00 |
| Dec 31, 2023 | -135,000.00 |